[go: up one dir, main page]

EE200300506A - 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis - Google Patents

3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis

Info

Publication number
EE200300506A
EE200300506A EEP200300506A EEP200300506A EE200300506A EE 200300506 A EE200300506 A EE 200300506A EE P200300506 A EEP200300506 A EE P200300506A EE P200300506 A EEP200300506 A EE P200300506A EE 200300506 A EE200300506 A EE 200300506A
Authority
EE
Estonia
Prior art keywords
diazabicyclo
prophylaxis
preparations
preparation
treatment
Prior art date
Application number
EEP200300506A
Other languages
English (en)
Inventor
Carlsson Hans
Larsson Anette
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0101326A external-priority patent/SE0101326D0/xx
Priority claimed from SE0101325A external-priority patent/SE0101325D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200300506A publication Critical patent/EE200300506A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EEP200300506A 2001-04-12 2002-04-12 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis EE200300506A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0101326A SE0101326D0 (sv) 2001-04-12 2001-04-12 Pharmaceutical formulation
SE0101325A SE0101325D0 (sv) 2001-04-12 2001-04-12 Pharmaceutical formulation
PCT/SE2002/000724 WO2002083687A1 (en) 2001-04-12 2002-04-12 3,7-diazybicyclo [3.3.1] formulations as antiarrhytmic compounds

Publications (1)

Publication Number Publication Date
EE200300506A true EE200300506A (et) 2004-02-16

Family

ID=26655442

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300506A EE200300506A (et) 2001-04-12 2002-04-12 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis

Country Status (23)

Country Link
US (1) US20040132798A1 (et)
EP (1) EP1389211A1 (et)
JP (1) JP2004525969A (et)
KR (1) KR20040005917A (et)
CN (1) CN1279916C (et)
AR (1) AR035807A1 (et)
BG (1) BG108235A (et)
BR (1) BR0208830A (et)
CA (1) CA2443464A1 (et)
CZ (1) CZ20032759A3 (et)
EE (1) EE200300506A (et)
HU (1) HUP0303481A3 (et)
IL (1) IL158035A0 (et)
IS (1) IS6990A (et)
MX (1) MXPA03009213A (et)
MY (1) MY141595A (et)
NO (1) NO20034528L (et)
NZ (1) NZ528559A (et)
PL (1) PL367182A1 (et)
RU (1) RU2003129229A (et)
SK (1) SK12542003A3 (et)
TW (1) TWI259836B (et)
WO (1) WO2002083687A1 (et)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
CA2409552A1 (en) 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
CA2595894C (en) 2005-01-31 2013-09-10 Kanji Takada Percutaneously absorbable preparation, percutaneously absorbable preparation holding sheet, and percutaneously absorbable preparation holding equipment
US7928225B2 (en) 2005-06-13 2011-04-19 Astrazeneca Ab Oxabispidine compounds for the treatment of cardiac arrhythmias
TW200940110A (en) * 2008-02-22 2009-10-01 Astrazeneca Ab Pharmaceutical formulation comprising oxabispidines
US10702485B2 (en) * 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3732094A1 (de) * 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
DE4402933A1 (de) * 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
SE9704709D0 (sv) * 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
TR200102911T2 (tr) * 1999-04-09 2002-01-21 Astrazeneca Ab Adamantan türevleri.
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
SE0101329D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab Pharmaceutical formulation
SE0101327D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab New crystalline forms

Also Published As

Publication number Publication date
NO20034528D0 (no) 2003-10-09
MY141595A (en) 2010-05-14
CZ20032759A3 (cs) 2004-01-14
JP2004525969A (ja) 2004-08-26
SK12542003A3 (sk) 2004-03-02
CN1514838A (zh) 2004-07-21
PL367182A1 (en) 2005-02-21
EP1389211A1 (en) 2004-02-18
IS6990A (is) 2003-10-10
TWI259836B (en) 2006-08-11
WO2002083687A1 (en) 2002-10-24
NO20034528L (no) 2003-12-08
US20040132798A1 (en) 2004-07-08
IL158035A0 (en) 2004-03-28
CA2443464A1 (en) 2002-10-24
RU2003129229A (ru) 2005-04-10
BR0208830A (pt) 2004-03-09
HUP0303481A2 (hu) 2004-01-28
MXPA03009213A (es) 2004-01-29
NZ528559A (en) 2005-03-24
CN1279916C (zh) 2006-10-18
KR20040005917A (ko) 2004-01-16
AR035807A1 (es) 2004-07-14
HUP0303481A3 (en) 2005-04-28
BG108235A (bg) 2005-04-30

Similar Documents

Publication Publication Date Title
EE04854B1 (et) Oksabispidiinühendid, nende valmistamise meetod ning ravimvorm kasutamiseks südame arütmia raviks ja profülaktikaks
EE200300504A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
EE04852B1 (et) C-21 modifitseeritud epotioloonid, nende valmistamise meetod ning kasutamine ja ravimkoostise kasutamine vähkkasvajate või teiste proliferatiivsete haiguste ravimisel
EE200300364A (et) 3,7-diasabitsüklo[3,3,0]oktaanid ja nende kasutamine südame arütmiate ravis
EE200100470A (et) Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine
EE05099B1 (et) Bradkardiaalsete toimeainete kasutamine hpertroofiaga seotud mokardiaalsete haiguste ravimiseks ja ravimikombinatsioonid
EE200200305A (et) Südame arütmiate ravis kasutatavad uued asabitsüklooktaani derivaadid
NO20020156D0 (no) Titanavledede forbindelser, fremstilling og anvendelse derav
EE200300495A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
EE200300506A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
AU2001296173A1 (en) 3,8-diazabicyclo(3.2.1)octanes and their use in the treatment of cardiac arrhythmias
NO20042846L (no) Derivater av 5-(pyridin-3-yl)-1-azabicyklo[3.2.1]oktan, fremstilling derav og anvendelse av de samme som terapeutiske midler
MXPA02012942A (es) Compuestos nuevos de bispidina y su uso en el tratamiento de arritmias cardiacas.
IS2380B (is) 3-Heteróarýl-3,5-díhýdró-4-oxó-4H-pýridasínó[4,5-b]indól-1-karboxamíð afleiður, framleiðsla þeirra og notkun þeirra við meðhöndlun
AU2001292500A1 (en) 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain
SI1360187T1 (en) 3,7-diazabicyclo(3.3.0)octanes and their use in the treatment of cardiac arrhythmias
PT1192156E (pt) Novos compostos de bispidina uteis no tratamento de arritmias cardiacas
ZA200109858B (en) New bispidine compounds useful in the treatment of cardiac arrhythmias.
HK1053647A (en) New bispidine compounds and their use in the treatment of cardiac arrhythmias
AU2002214441A1 (en) 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain
MXPA03004074A (es) Derivados de retiferol y su uso en el tratamiento de enfermedades o trastornos de la piel asociadas con fotoda°o.
AU2002368208A1 (en) Use of 2,3 alkylcarbonyloxybenzoic acids in the treatment of anthrax
AUPQ790300A0 (en) Diagnosis, prophylaxis and treatment of hepatitis C
NO981460D0 (no) Preparat for behandling og/eller profylakse av hudlidelser, samt anvendelse derav